Bronchoalveolar levels of plasminogen activator inhibitor-1 and soluble tissue factor are sensitive and specific markers of pulmonary inflammation.

Bronchoalveolar levels of plasminogen activator inhibitor-1 and soluble tissue factor are sensitive and specific markers of pulmonary inflammation.

Bibliographic Details
Main Authors:	Determann, R, Millo, J, Garrard, C, Schultz, M
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia.
by: Determann, R, et al.
Published: (2005)

Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke
by: Keiji Hasumi, et al.
Published: (2021-01-01)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2011)

Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2012)

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation
by: Célia Seillier, et al.
Published: (2024-02-01)

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
by: Kota Hoshino, et al.
Published: (2017-07-01)

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.
by: Kjellman, A, et al.
Published: (2011)

The neurotoxicity of tissue plasminogen activator?
by: Kaur, J, et al.
Published: (2004)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
by: Marie Mennesson, et al.
Published: (2023-02-01)

Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
by: Juanzhen Li, et al.
Published: (2022-05-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
by: Ebers, G
Published: (1988)

Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema
by: Matthias Peter Hilty, et al.
Published: (2016-01-01)

Air pollutants in bronchoalveolar lavage fluid and pulmonary tuberculosis: A mediation analysis of gene-specific methylation
by: Qiao Liu, et al.
Published: (2023-12-01)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
by: Matilde Kanstrup Andersen BA, et al.
Published: (2023-09-01)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
by: Shengyuan Luo, et al.
Published: (2022-09-01)

Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System
by: María Teresa Herrera, et al.
Published: (2022-08-01)

Bronchoalveolar lavage in diagnostic evaluation of pulmonary diseases- An institutional experience
by: Swalaha Sadaf Siddiqui, et al.
Published: (2023-01-01)

The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity
by: Tetiana Yatsenko, et al.
Published: (2023-01-01)

Osteopontin and fibronectin in lung tissue, serum, and bronchoalveolar lavage fluid of dogs with idiopathic pulmonary fibrosis and control dogs
by: Aline Fastrès, et al.
Published: (2023-11-01)

Tissue Plasminogen Activator and DNase in Empyema REPLY
by: Rahman, N, et al.
Published: (2011)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.
by: Millo, J, et al.
Published: (2004)

Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study
by: Xiaoyan Si, et al.
Published: (2023-07-01)

Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease
by: Ahmed Al‐Badri, et al.
Published: (2020-04-01)

Endotoxin markers in bronchoalveolar lavage fluid of patients with interstitial lung diseases
by: Szponar Bogumiła, et al.
Published: (2012-12-01)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
by: Renata Marietta Bocskei, et al.
Published: (2020-02-01)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022-09-01)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
by: Nergiz Erkut, et al.
Published: (2016-05-01)

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
by: Per Wittenhagen, et al.
Published: (2011-01-01)

The different expressions of urokinasetype plasminogen activator, urokinasetype plasminogen activator receptor, and plasminogen activator inhibitor-1. Several scores of cell pleomorphism, number of mitosis and keratiniza
by: Perpustakaan UGM, i-lib
Published: (2008)

The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
by: Nina C. Teske, et al.
Published: (2022-10-01)

Does plasminogen activator inhibitor-1 drive lymphangiogenesis?
by: Françoise Bruyère, et al.
Published: (2010-01-01)

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
by: Tetiana Yatsenko, et al.
Published: (2024-01-01)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022-08-01)

Plasminogen Activator Inhibitor-1 as a Marker of Thrombosis among Prehypertensive Patients: A Cross-sectional Study
by: B Umadevi, et al.
Published: (2023-08-01)

Index of Body Inflammation for Maxillofacial Surgery Purpose-to Make the Soluble Urokinase-Type Plasminogen Activator Receptor Serum Level Independent on Patient Age
by: Marcin Kozakiewicz, et al.
Published: (2021-02-01)

Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity
by: Ayumi Fukakusa, et al.
Published: (2008-01-01)

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
by: George Hindy, et al.
Published: (2022-12-01)